Research Research at the Institute of Transfusion Medicine and Transplant Engineering All research at the Institute of Transfusion Medicine and Transplant Engineering is designated to biotechnology approaches [...] 532 6704 F +49 511 532 2079 Immenschuh.Stephan @ mh-hannover.de Cellular Immunotherapy This area of research focuses on the development of personalized antigen-specific T cell immunotherapies. A long standing [...] after allogeneic or xenogeneic transplantation. Advanced gene regulatory and gene editing approaches, ex situ perfusion as well as tissue and organ engineering strategies are combined to generate immunologically

Ferreira de Figueiredo (Transfusion Medicine) Project: Correction of monogenetic kidney diseases using a gene therapeutic approach Aavani Biju Sindhu INDIA; Sindhu.Aavani @ mh-hannover.de Supervisor: Prof [...] ITALY; Cipriani.Giuseppe @ mh-hannover.de Supervisors: Dr. Natalie Weber/ Prof. Dr. Thomas Thum (Institute of Molecular and Translational Therapeutic Strategies IMTTS and Fraunhofer ITEM) Project: Integration [...] Anita Koula Pralas GERMANY; Pralas.Anita-Koula @ mh-hanover.de Supervisor: PD Dr. Christian Bär (Institute of Molecular and Translational Therapeutic Strategies, IMTTS) Project: The role of the lncRNA Meg3

Neurologie Institut für Biometrie Institut für Klinische Pharmakologie Klinik für Nuklearmedizin Kooperationspartner Extern - Deutschlandweit Section Biostatistics am Paul-Ehrlich-Institut Klinik für [...] Unit, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig MPI Germany Massachusetts General Hospital, Harvard Medical School Harvard-MGH USA Rensselaer Polytechnic Institute RPI USA Toure [...] Therapieansätzen und den Ursachen des Tourette-Syndroms durch. Unter der Leitung von Frau Prof.‘in Kirsten R. Müller-Vahl wurden in den vergangenen Jahren 15 Promotionen abgeschlossen. Aktuell werden in der A

function. In 2022 he joined the AG Münster-Kühnel in the Institute of Clinical Biochemistry in the MHH, first as a guest PhD student, then as a postdoctoral researcher. As part of the nextGENERATION Medical [...] Mitarbeiterin in der Arbeitsgruppe „Molekulare Immuntherapie“ von Prof. Dr. Britta Eiz-Vesper im Institut für Transfusionsmedizin und Transplantat Engineering an der Medizinischen Hochschule Hannover tätig [...] Erkrankungen in der Arbeitsgruppe „Molekulare Immuntherapie“ von Prof. Dr. Britta Eiz-Vesper im Institut für Transfusionsmedizin und Transplantatengineering der MHH (2018-2021) und wurde dafür 2022 mit

Research Topic: The immunoregulatory role of the C3a/C3R axis in experimental chlamydial lung Infection’ Supervisor: Prof. Dr. Andreas Klos, Institute for Medical Microbiology and Hospital Epidemiology [...] Dr. Thomas Schulz, Institute of Virology, Hannover Medical School Academic Background: Molecular Genetics, Mahi-dol University, Thailand Sandra Koch Research Topic: A novel role for a viral interferon [...] the role of neonatal toll like receptor 7 in a VSV infection model Supervisor: Prof. Dr. Tim Sparwasser, Institute for Infection Immunology, Twincore Institute Academic Background: Microbiology, University

Zheng M, Popp J, Eckert K, Geidl W, Blaschke S, Schmid J, Grüne E, Oppermann L , Liphardt A-M, Morf H, Weissenfels A, Pfeifer K (2024). Competencies for health-enhancing physical activity are associated with [...] health competence using digital workplace-based health promotion: protocol for a controlled before-and-after study. BMJ Open Sp Ex Med 2023; 9:e001464. doi: 10.1136/bmjsem-2022-001464 Häberle N, Oppermann L [...] am Hochschulsport Göttingen im Projekt Healthy Campus – Gesundheitsförderung für Studierende, am Institut für Sportwissenschaften im Arbeitsbereich Sport- und Gesundheitssoziologie sowie an der Hochsch

for each growth factor as a subgroup analysis using OR in a fixed-effect model. We evaluated the robustness of the results in a sensitivity analysis using risk ratio (RR) and/or a random-effects model. We [...] Hagen A, Krauth C, Gerhardus A, Schwartz FW. Der Analytic Hierarchy Process (AHP) als Methode bei innovationsbezogenem Health Technology Assessment. Das Gesundheitswesen 2003, 8/9: A21. Hagen A, Dintsios [...] is associated with a high clinical and socioeconomic burden. Treatments to alleviate the symptoms of PAD and decrease the risks of amputation and death are a high societal priority. A number of growth factors

experience-dependent plasticity as a prerequisite for flexible behavior. Therefore, pathology-driven changes in the ability for homeostatic plasticity expression might represent a hallmark for the development [...] Transplantation and Vascular Surgery. The work is funded by a contract of the German Armed Forces (2022-2024). We have recently established a protocol for deriving human Schwann cells from human iPSCs and [...] pathophysiology of neuropsychiatric disorders. Ex vivo inter-organ communication: The performance of our brain relies on internal body conditions, which are regulated by a complex interplay of different organs

experience-dependent plasticity as a prerequisite for flexible behavior. Therefore, pathology-driven changes in the ability for homeostatic plasticity expression might represent a hallmark for the development [...] Transplantation and Vascular Surgery. The work is funded by a contract of the German Armed Forces (2022-2024). We have recently established a protocol for deriving human Schwann cells from human iPSCs and [...] pathophysiology of neuropsychiatric disorders. Ex vivo inter-organ communication: The performance of our brain relies on internal body conditions, which are regulated by a complex interplay of different organs

Wunderlich S, Haase A, Merkert S, Jahn K, Deest M, Frieling H, Glage S, Korte W, Martens A, Kirschning A, Zeug A, Ponimaskin E, Göhring G, Ackermann M, Lachmann N, Moritz T, Zweigerdt R, Martin U. Targeted [...] Mol Ther Methods Clin Dev) Referenzen: Kosanke M, Osetek K, Haase A, Wiehlmann L, Davenport C, Schwarzer A, Adams F, Kleppa MJ, Schambach A, Merkert S, Wunderlich S, Menke S, Dorda M, Martin U. Reprogramming [...] arbeiten wir u.a. an der Entwicklung neuer Therapiekonzepte, bei denen alternative Ionenkanäle beeinflusst werden. Projekte im Bereich iPS Zell-basierte Krankheitsmodelle Evaluation of TMEM16A as a modifier